you can edit this section directly in HTML ( templates > custom template > html )
Vivos Inc. Announces Listing to the OTCQB
Richland WA, Sept. 18, 2019 (GLOBE NEWSWIRE) -- Vivos Inc. (OTCQB: RDGL), Vivos Inc. a company engaged in the development and commercialization of minimally
invasive brachytherapy treatments to combat cancer in animals and humans, today announced that its common shares have been approved for trading on the OTCQB Marketplace (OTCQB) under the symbol
“RDGL” effective as of the open of trading today.
"The listing of our common stock to the OTCQB Exchange is an important milestone for Vivos Inc," said Mike Korenko Vivos Inc CEO. “We look forward to continuing to increase the visibility of
Vivos Inc. and believe that the broader exposure afforded by the OTCQB is another important step in that process. We are working diligently to increase the investment community’s awareness of
Vivos Inc. as part of our larger mandate to inform the veterinary and medical community about Isopet® and Radiogel™.”
The OTCQB is a venture market operated by OTC Markets Group and designed for early-stage and developing US and international companies. To be eligible, companies must be current in their
reporting and undergo an annual verification and management certification process. To learn more, visit otcmarkets.com.